Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tezepelumab (Tezspire) Regulatory Postmarketing Surveillance in Korea

NCT06998095 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT06998095
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06998095 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tezepelumab (Tezspire) Regulatory Postmarketing Surveillance in Korea
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Not yet recruiting
Start date
November 28, 2026
Completion date
October 31, 2029
Enrollment
210 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chronic rhinosinusitis with nasal polyps(crswnp), severe asthma